tiprankstipranks
Advertisement
Advertisement

BCRX Stock Latest News

BioCryst Earnings Call: ORLADEYO Momentum vs. Risks
Company AnnouncementsBioCryst Earnings Call: ORLADEYO Momentum vs. Risks
2d ago
BCRX
BioCryst price target raised to $28 from $25 at Citizens
PremiumThe Fly
BioCryst price target raised to $28 from $25 at Citizens
15d ago
BCRX
BioCryst reports Q1 EPS ($2.98), consensus 11c
PremiumThe Fly
BioCryst reports Q1 EPS ($2.98), consensus 11c
15d ago
BCRX
BioCryst backs FY26 revenue view $635M-$660M, consensus $650.22M
PremiumThe Fly
BioCryst backs FY26 revenue view $635M-$660M, consensus $650.22M
15d ago
BCRX
BioCryst Earnings Call: Growth, Pipeline And New Risks
PremiumCompany Announcements
BioCryst Earnings Call: Growth, Pipeline And New Risks
15d ago
BCRX
BioCryst Buy Rating Reiterated on Orladeyo Strength, Long-Term Growth Potential and Unchanged $30 Price Target
PremiumRatingsBioCryst Buy Rating Reiterated on Orladeyo Strength, Long-Term Growth Potential and Unchanged $30 Price Target
16d ago
BCRX
BioCryst Posts Q1 2026 Results, Maintains Growth Outlook
Premium
Company Announcements
BioCryst Posts Q1 2026 Results, Maintains Growth Outlook
16d ago
8K
BCRX
BioCryst Licenses European Rights to HAE Drug Navenibart
Premium
Company Announcements
BioCryst Licenses European Rights to HAE Drug Navenibart
18d ago
8K
BCRX
BioCryst enters navenibart license agreement with Neopharmed Gentili
PremiumThe Fly
BioCryst enters navenibart license agreement with Neopharmed Gentili
18d ago
BCRX
BioCryst Pharmaceuticals (BCRX) Q1 Earnings Cheat Sheet
PremiumPre-Earnings
BioCryst Pharmaceuticals (BCRX) Q1 Earnings Cheat Sheet
18d ago
BCRX
3 ‘Perfect 10’ Smart Score Stocks to Buy this Week, 4/13/26, According to Analysts
PremiumMarket News
3 ‘Perfect 10’ Smart Score Stocks to Buy this Week, 4/13/26, According to Analysts
1M ago
ANET
BCRX
BioCryst price target raised to $14 from $13 at RBC Capital
PremiumThe Fly
BioCryst price target raised to $14 from $13 at RBC Capital
1M ago
BCRX
BioCryst appoints Sandeep Menon as chief research and development officer
PremiumThe FlyBioCryst appoints Sandeep Menon as chief research and development officer
2M ago
ALNY
BCRX
EOG, GitLab, StoneCo, Cipher, BioCryst Insider Shake-Up
Premium
Weekend Updates
EOG, GitLab, StoneCo, Cipher, BioCryst Insider Shake-Up
2M ago
EOG
BCRX
3 Best Value Stocks with Over 20% Upside in 2026, According to Analysts 
Premium
Market News
3 Best Value Stocks with Over 20% Upside in 2026, According to Analysts 
2M ago
DOX
BCRX
BioCryst reports inducement grants under Nasdaq listing rule
PremiumThe Fly
BioCryst reports inducement grants under Nasdaq listing rule
3M ago
BCRX
BioCryst price target raised to $22 from $21 at Wedbush
PremiumThe Fly
BioCryst price target raised to $22 from $21 at Wedbush
3M ago
BCRX
Brand Risks Emerge in BioCryst’s ORLADEYO Sale to Neopharmed as Fragmented Positioning Threatens Long‑Term Value
PremiumCompany Announcements
Brand Risks Emerge in BioCryst’s ORLADEYO Sale to Neopharmed as Fragmented Positioning Threatens Long‑Term Value
3M ago
BCRX
BioCryst Earnings Call Highlights Profits, Pipeline Momentum
PremiumCompany Announcements
BioCryst Earnings Call Highlights Profits, Pipeline Momentum
3M ago
BCRX
BioCryst Boosts HAE Franchise With Astria Acquisition, Guidance
PremiumCompany AnnouncementsBioCryst Boosts HAE Franchise With Astria Acquisition, Guidance
3M ago
8K
BCRX
BioCryst reports Q4 EPS $1.12 vs (13c) last year
Premium
The Fly
BioCryst reports Q4 EPS $1.12 vs (13c) last year
3M ago
BCRX
BioCryst sees FY26 revenue $635M-$660M, consensus $657.1M
Premium
The Fly
BioCryst sees FY26 revenue $635M-$660M, consensus $657.1M
3M ago
BCRX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >